-
Study aim
-
Evaluation the effectiveness and comparing of True and Sham Thread Embedding in acupoints on Spasticity in Multiple Sclerosis
-
Design
-
A concealed, block randomized, double-blinded, 3rd phase of sham controlled clinical trial with a parallel group design of 38 patients
-
Settings and conduct
-
Patients referred to the neurology clinic of Mashhad Qaem Hospital, suffering from RRMS in the recovery phase, according to the inclusion criteria and the approval of the MS fellowship, are referred to the acupuncture clinic of Imam Reza hospital. After signing the informed consent form, first evaluations are performed. In addition to the routine neurological treatment, the participants are placed in two groups and 30 acupoints are intervented. In True Embedding intervention group, after disinfection, 2cm PDO threads are embedded in the acupoints by a 20 gauge needle. In the Sham control group, the needle is inserted in the same points for blinding, but the thread is not embedded in the tissue. To prevent infection, cephalexin and to control pain, cold compress or Ibuprofen are prescribed. After 4 and 12 weeks, the outcomes are evaluated.
-
Participants/Inclusion and exclusion criteria
-
Inclusion Criteria: Definite diagnosis of MS; EDSS<7; Age>18; Resistant spasticity; Signing informed consent. Non-Inclusion Criteria: Receiving acupuncture in the last 6 months; Relapse or changing maintenance treatment in the last 2 months; Severe chronic systemic disease, cancers and coagulopathy; Sensitivity to Cephalosporins or thread; Pregnancy, Breastfeeding or uncertain contraception
-
Intervention groups
-
Intervention group: True Embedding of Polydioxanone Threads in 30 Acupoints. Sham control group: Needling in 30 Acupoints Without inserting Threads
-
Main outcome variables
-
Disability, Spasm, Walking quality, Daily life activities, Pain, Fatigue, Sleep, Urinary symptoms, Depression, Anxiety and Quality of life score